Inda muka ci gaba alama ba kawai ƙarshen sarkar peptide ba amma farkon mafi kyawun kiwon lafiya. Tare da haɓakar fasaha kamar fasahar mu da nasarar abokin ciniki a matsayin kamfas ɗin mu, JYMed ya jajirce don zama jagorar duniya a cikin ayyukan peptide CRDMO. Muna sa ido ga haɓaka ƙimar haɗin gwiwa, samun haɗin gwiwar nasara-nasara, da ba da gudummawa ga ci gaban lafiya na masana'antar peptide na duniya.

Game da JYMed

JYMed wani kamfani ne mai sarrafa magunguna wanda ya ƙware wajen haɓakawa, masana'antu, da kasuwancin samfuran tushen peptide. Muna ba da sabis na CDMO na ƙarshe zuwa ƙarshe don magunguna, kayan kwalliya, da abokan aikin dabbobi a duk duniya.

Fayil ɗin samfurin mu ya haɗa da kewayon peptide APIs, gami da Semaglutide da Tirzepatide, waɗanda dukkansu sun sami nasarar kammala fassarori na FDA DMF na Amurka.

Hannun masana'antar mu, Hubei JXBio, tana aiki da layin samar da peptide API wanda ya dace da ka'idodin cGMP daga FDA ta Amurka da NMPA ta China. Shafin yana fasalta manyan layukan ma'auni 10 da matukin jirgi kuma ana samun goyan bayan ingantaccen QMS da cikakken tsarin EHS.

JXBio ya wuce binciken GMP ta FDA ta Amurka da NMPA na kasar Sin kuma manyan kamfanonin harhada magunguna sun amince da su don sadaukar da kai ga aminci, inganci, da alhakin muhalli.

BABBAN KAYANA